Evidence map›Paper›PMID 26378781›Full record

ArticlePloS one2015

Structural and Biochemical Analysis of a Single Amino-Acid Mutant of WzzBSF That Alters Lipopolysaccharide O-Antigen Chain Length in Shigella flexneri.

Chiung-Wen Chang, Elizabeth N H Tran, Daniel J Ericsson, Lachlan W Casey, Thierry Lonhienne, Friederike Benning, Renato Morona, Bostjan Kobe

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chiung-Wen ChangSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane Qld 4072, Australia; Institute for Molecular Bioscience, University of Queensland, Brisbane Qld 4072, Australia; Australian Infectious Disease Research Centre, University of Queensland, Brisbane Qld 4072, Australia.
Elizabeth N H TranSchool of Biological Sciences, Department of Molecular and Cellular Biology, University of Adelaide, Adelaide 5005, Australia.
Daniel J EricssonSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane Qld 4072, Australia; Institute for Molecular Bioscience, University of Queensland, Brisbane Qld 4072, Australia; Australian Infectious Disease Research Centre, University of Queensland, Brisbane Qld 4072, Australia.
Lachlan W CaseySchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane Qld 4072, Australia; Institute for Molecular Bioscience, University of Queensland, Brisbane Qld 4072, Australia; Australian Infectious Disease Research Centre, University of Queensland, Brisbane Qld 4072, Australia.
Thierry LonhienneSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane Qld 4072, Australia.
Friederike BenningSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane Qld 4072, Australia; Institute for Molecular Bioscience, University of Queensland, Brisbane Qld 4072, Australia; Australian Infectious Disease Research Centre, University of Queensland, Brisbane Qld 4072, Australia.
Renato MoronaSchool of Biological Sciences, Department of Molecular and Cellular Biology, University of Adelaide, Adelaide 5005, Australia.
Bostjan KobeSchool of Chemistry and Molecular Biosciences, University of Queensland, Brisbane Qld 4072, Australia; Institute for Molecular Bioscience, University of Queensland, Brisbane Qld 4072, Australia; Australian Infectious Disease Research Centre, University of Queensland, Brisbane Qld 4072, Australia.
University of Queensland · AUUniversity of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopolysaccharide (LPS), a surface polymer of Gram-negative bacteria, helps bacteria survive in different environments and acts as a virulence determinant of host infection. The O-antigen (Oag) component of LPS exhibits a modal chain-length distribution that is controlled by polysaccharide co-polymerases (PCPs). The molecular basis of the regulation of Oag chain-lengths remains unclear, despite extensive mutagenesis and structural studies of PCPs from Escherichia coli and Shigella. Here, we identified a single mutation (A107P) of the Shigella flexneri WzzBSF, by a random mutagenesis approach, that causes a shortened Oag chain-length distribution in bacteria. We determined the crystal structures of the periplasmic domains of wild-type WzzBSF and the A107P mutant. Both structures form a highly similar open trimeric assembly in the crystals, and show a similar tendency to self-associate in solution. Binding studies by bio-layer interferometry reveal cooperative binding of very short (VS)-core-plus-O-antigen polysaccharide (COPS) to the periplasmic domains of both proteins, but with decreased affinity for the A107P mutant. Our studies reveal that subtle and localized structural differences in PCPs can have dramatic effects on LPS chain-length distribution in bacteria, for example by altering the affinity for the substrate, which supports the role of the structure of the growing Oag polymer in this process.

Indexed as

Amino AcidsBacterial ProteinsCrystallography, X-RayEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialLipopolysaccharidesMutagenesisMutationO AntigensProtein Structure, TertiaryShigella flexneriAmino AcidsBacterial ProteinsEscherichia coli ProteinsLipopolysaccharidesO Antigensrol protein, Bacteria

Identifiers

PMID26378781
PMCPMC4574919
OpenAlexW1949517675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.